Home > PJ (current issue) > The Society / Daily News | Search

The Pharmaceutical Journal
Vol 273 No 7307 p67
10 July 2004


Society summary


Council to ballot membership on amended proposal for new Charter

Members of Royal Pharmaceutical Society are to be balloted later this month on a revised version of the Council's proposal for a new Charter. The revised version will be published in full next week, with an article explaining the changes, in a pull-out section of The Pharmaceutical Journal. A summary of the main changes to the draft new Charter appears on p68.

Some of the changes that the Council wishes to propose to the Privy Council arise from concerns expressed by members. Others are changes proposed by the Privy Council itself, which the Council has agreed to accept.

Ballot papers and supporting materials will be sent out on or around July 16. The ballot will ask members whether or not they approve of the revised version of the draft new Charter. The Society will also establish an e-mail address for members who wish to raise points or ask questions.

The decision to revise the draft Charter and ballot the membership was made at a special Council meeting on 30 June. This followed a two-day strategy meeting at which further consideration was given to the wording of the draft Charter that has been in the hands of the Privy Council since December 2003.

The Privy Council was informed after the Council’s meeting on 8 and 9 June that, without prejudicing its ability to withdraw its Charter petition, the Council wished to submit changes to the draft Charter after further consideration by the Council and the membership (PJ, 19 June, p775).

When the matter of the Charter was considered by the Council at its special meeting, it had before it a revised version of the draft Charter containing all the changes the Council had discussed and approved during its strategy meeting. Asking the Council to accept the document, the President said that he hoped the decision would be swift and unanimous.

The President proposed that the Council should take the revised draft to the membership as its recommended or preferred Charter.

A vote was then taken. There were 21 votes for the proposal and no votes against. Sultan Dajani abstained.

Michael Schofield reported that Bob Michell (who was absent because he was attending the first meeting of a new NHS trust) would have wished to support the proposal.

The President thanked the Council for their hard work. He also thanked Robert Bulling, of Allen & Overy (an expert in the law relating to chartered bodies) and members of the Society’s staff for their assistance.

Later, closing the meeting, the President reminded the Council that they were bound by the code of conduct for Council members. Following the declaration they had all signed regarding corporate governance, any Council members who chose to speak out against the agreements they had made would need to make a declaration now.

No Council members made such a declaration.

Statement by the immediate past president

After the Council had made its decision to ballot the membership on a revised draft new Charter, Gill Hawksworth, as immediate past president, made the following statement :


“I am very pleased to say that when I, as president, supported by the previous vice-president and treasurer, suggested a way forward — a window of opportunity to save the Charter — at the last Council meeting, I could only hope that the issues that separated Council colleagues could be reconciled to allow us to complete our modernisation work and the Charter in time before the Section 60 Order was sent out to consultation. I am grateful that Council colleagues used the time well and thank them for agreeing with me that this was and has been achievable. The profession can now move forward to the next stage of the process. I am proud that I was able to contribute this solution as my last duty as president.”


The President said that he endorsed Dr Hawksworth’s comments and thought it was an important statement. He was sure that all Council members would share his view that thanks were due to Dr Hawksworth for her work.

Back to Top


©The Pharmaceutical Journal